Skip to main content

Hepatic Metastases from Non Colorectal Cancer: Which Ones Should be Resected?

  • Chapter
Advances in Abdominal Surgery 2002

Abstract

Background and objectives While liver resection for metastatic disease from colorectal cancer is likely to extend survival in selected patients, the efficacy of hepatic resection as treatment for metastases from other malignancies has not yet been defined.

Methods Between 1988 and 2000, 26 hepatic resections were performed on 24 patients (two patients underwent a double resection due to recurrence), as treatment of non-colorectal metastases. One, two, five years’ overall and disease-related actuarial survival (sec. Kaplan-Meier) have been calculated.

Results No intraoperative or early post-operative deaths were reported. Seven minor (30%) and one major (5%) post operative complications occurred; the mean blood loss was 401 +/− 324 ml; in 75% of patients, no intra/post operative blood transfusion was needed. The mean post-operative hospital stay was 13.2 days (9–23).

The overall actuarial survival rate was 54% at one year, 42% at two years and 21% at five years (mean 38 ± 11 months). Survival is related to the primary tumor nature and stage.

Conclusions Hepatic resection for metastases from non-colorectal carcinoma is safe and feasible, with relatively low incidence of intra/post-operative complications, and short hospital stay. Although it achieves good results in terms of survival only in patients suffering from neuroendocrine metastases, it could also have a cytoreductive effect for other tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dionigi R, Benevento A. Il fegato. In Dionigi R. (eds):“ Chirurgia” Milano: Masson, 1998: 1261–1270.

    Google Scholar 

  2. Foster JH, Lundy J. Liver metastases. Curr Probl Surg 1981; 18: 161–201.

    Article  Google Scholar 

  3. Dionigi R, Madiaraga J (eds.). “New technologies for liver resection”. New York: Landes, 1998.

    Google Scholar 

  4. Hughes K, Simon R et al. Registry of hepatic metastases. Resection of the liver for colorectal carcinoma metastases: a multi-istitutional study for indication of resection. Surgery 1988; 103: 278–287.

    Google Scholar 

  5. Wolf RF, Goodnight JE, Krag DE et al. Results of resection and proposed guidelines for patient selection in instanced of noncolorectal hepatic metastases. Gynec Obstet 1991; 173: 454–460.

    CAS  Google Scholar 

  6. Mariette D, Fagniez PL. Hepatic metastasis of non-colorectal cancers. Result of surgical treatment. Rev Prat 1992; 42: 1271–1275.

    PubMed  CAS  Google Scholar 

  7. Chen H, Hardacre JM, Uzar A et al. Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? JAm Coll Surg 1998; 187: 88–93.

    Article  CAS  Google Scholar 

  8. Cozzi PJ, Englund R, Morris D. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer 1995; 73: 501–519.

    Article  Google Scholar 

  9. Lang H, Oldhafer KJ, Weimann A et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997; 225: 347–354.

    Article  PubMed  CAS  Google Scholar 

  10. LeTreut YP, Delpero JR, Dousset B et al. Result of liver transplantation for metastatic neuroendocrine tumors: a 31-case French multicentric report. Ann Surg 1997; 225: 355–364.

    Article  CAS  Google Scholar 

  11. Siperstein AE, Rogers SJ, Hansen PD et al. Laparoscopie thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997; 12: 1147–1155.

    Article  Google Scholar 

  12. Frame J, Kelson D, Kemeny N et al. A phase II trial of streptocin and adriamycin in advanced APUD tumor. Am J Clin Oncol 1988; 11: 490–495.

    Article  PubMed  CAS  Google Scholar 

  13. Moertal CG, Kvols D, O’Connell MJ et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of this neoplasm. Cancer 1991; 68: 227–232.

    Article  Google Scholar 

  14. Perry LJ, Stuart K, Stokes KR et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994; 166: 1111–1117.

    Google Scholar 

  15. Ochiai T, Sasako M, Mizuno S et al. Hepatic resection for metastatic tumors from gastric cancer: analysis of prognostic factors. BrJSurg 1991; 78: 797–801.

    Google Scholar 

  16. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastases from colorectal carcinoma: morbidity, mortality and pattern of recurrence. Ann Surg 1989; 209: 428–434.

    Article  PubMed  CAS  Google Scholar 

  17. Ekberg H, Tranberg KG, Andersson T et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73: 727–731.

    Article  PubMed  CAS  Google Scholar 

  18. Isono T, Miyazaki M, Udagawa I et al. The clinicopathological study of intrahepatic micro-metastases of gastric cancer and colorectal cancer. J JPN Soc Cancer Therapy 1992; 27: 893–898.

    Google Scholar 

  19. Miyazaki M, Itoh H, Nakagawa K et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997; 97: 490–493.

    Google Scholar 

  20. Elias D, Lasser PH, Montruccoli D, et al. Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol 1995; 21 (5): 510–513.

    Article  PubMed  CAS  Google Scholar 

  21. Elias D, Lasser P, Spielmann M et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gyncol Obstet 1991; 172: 461–464.

    CAS  Google Scholar 

  22. Schneebaum S, Walker M, Young D et al. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994; 55: 26–32.

    Article  PubMed  CAS  Google Scholar 

  23. Shwartz SI. Hepatic resection for non colorectal non neuroendocrine metastases. World J Surg 1995; 19: 72–75.

    Article  Google Scholar 

  24. Harris J, Morrow M, Norton L. Malignant tumors of the breast. In: DeVita VT Jr, Hellman S, Rosemberg SA, (eds) “Cancer: Principles and Practice of Oncology”. Philadelphia: Lippiconcott-Raven, 1997: 1557–1616.

    Google Scholar 

  25. Fumoleau P. Treatment of patients with liver metastases. Anticancer Drugs 1996; 7: 21–23.

    PubMed  CAS  Google Scholar 

  26. Alexander HR, Kelsen DG, Tepper JC. Cancer of the stomach. In: DeVita VT Jr, Hellman S, Rosemberg SA, (eds.) “Cancer: Principles and Practice of Oncology”. Philadelphia: Lippiconcott-Raven, 1997; 1054–87.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Benevento, A., Boni, L., Dionigi, G., Dionigi, R. (2002). Hepatic Metastases from Non Colorectal Cancer: Which Ones Should be Resected?. In: Farinon, A.M. (eds) Advances in Abdominal Surgery 2002. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0637-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0637-7_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-6135-5

  • Online ISBN: 978-94-017-0637-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics